Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
News
Video
Updates on Schizophrenia at the 2023 Psychiatric Times World CME Conference
Author(s):
Don't miss updates on schizophrenia at our conference, beginning at 3:10PM EST!
Video Player is loading.
John J. Miller, Editor in Chief of Psychiatric Times, will present in the first hour of our conference, which focuses on schizophrenia.
You can join the conversation here.
Dr Miller is Medical Director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric Times®; Staff Psychiatrist, Seacoast Mental Health Center, Exeter; Consulting Psychiatrist, Exeter Hospital, Exeter; Consulting Psychiatrist, Insight Meditation Society, Barre, Massachusetts.
Related Videos
Cobenfy as an Adjunctive Agent in Schizophrenia: Peter J. Weiden, MD, Shares Insights on the Latest Findings
Medications for Different Domains of Schizophrenia
Educating Patients About Cobenfy for the Treatment of Schizophrenia
Answering 3 Clinical Questions in the Wake of the Removal of the Clozapine REMS Requirement
A Clinical Challenge: Transitioning Patients to Cobenfy
Cognitive Issues in Schizophrenia Remain a Challenge
Reset the Clock on Schizophrenia: SPG302, A Regenerative Treatment
A Welcome Action: Removal of the REMS Requirement for Clozapine
Behind the Steering Wheel of Your Brain: Residual Negative and Cognitive Symptoms in Schizophrenia
LB-102: A New, Novel Drug for Schizophrenia
Related Content
